Anzeige
Erschienen in:
31.01.2020 | Letter to the Editor
A Follow-Up to “Complication of AQUAfilling® Gel Injection for Breast Augmentation: Case Report of One Case and Review of Literature”
Erschienen in: Aesthetic Plastic Surgery | Ausgabe 2/2020
Einloggen, um Zugang zu erhaltenExcerpt
The authors of “Complication of AQUAfilling® Gel Injection for Breast Augmentation: Case Report of One Case and Review of Literature” would like to address the concerns brought forth by Biotrh with regard to their product, AQUAfilling:
1.
Steps were taken to clarify the brand of filler material discussed in our study. After inquiring with both the patient and relevant clinic, it was confirmed that the filler material used for the procedure was indeed AQUAfilling gel. The retrieval of the product number for this particular product would require a court order to investigate the patient’s chart since the patient herself was not willing to return to the clinic.
2.
The doctor who carried out the initial AQUAfilling procedure was not able to report the complication incident to the manufacturer, since the patient did not return to the clinic, but instead consulted a general surgery colleague and was subsequently referred to our department.
3.
The product reference in citation 6 is AQUAfilling in nature, although the authors have not used registered marking in the journal. We accept that the references 10, 11, 12 are based on polyacrylamide gel in general and are not directly related to the product described in the article.